[
  {
    "ts": null,
    "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now",
    "summary": "VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.",
    "url": "https://finnhub.io/api/news?id=f3e7c4f2c6d0444eead7ed29f5059ca4c49ac00247e241f5223625d897bfacb7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760549640,
      "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now",
      "id": 137097040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.",
      "url": "https://finnhub.io/api/news?id=f3e7c4f2c6d0444eead7ed29f5059ca4c49ac00247e241f5223625d897bfacb7"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now",
    "summary": "WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.",
    "url": "https://finnhub.io/api/news?id=af035cbce7fd4c60ea0308b0e4da4e096ca616aceb29defe0bb5292ab2b92118",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760529780,
      "headline": "Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now",
      "id": 137094656,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.",
      "url": "https://finnhub.io/api/news?id=af035cbce7fd4c60ea0308b0e4da4e096ca616aceb29defe0bb5292ab2b92118"
    }
  }
]